Anil Potti resurfaces at South Carolina cancer center

courtesy Duke

Anil Potti, the oncologist who has been forced to retract four papers because of results that could not be reproduced, and resigned last fall from Duke, has a new job. He’s joined the Coastal Cancer Center, an oncology practice with four offices in South Carolina and one in North Carolina.

The Duke Fact Checker was apparently the first to report the news. The Cancer Letter, which has been out front on the Potti story for a year, first reported the news.*

It’s not surprising that Potti’s Coastal Center bio leaves out any mention of his troubled research and the fact that he faked a Rhodes scholarship on a grant application. Investigations into what happened at Duke are ongoing. Continue reading Anil Potti resurfaces at South Carolina cancer center

Applied Mathematics Letters posts apology for retracting Intelligent Design-friendly paper

Applied Mathematics Letters, which agreed to apologize to Intelligent Design-friendly Texas professor Granville Sewell and have its publisher, Elsevier, pay $10,000 in legal fees, has posted the text of its apology (Of note: Elsevier has the apology behind a paywall. So if 318 people fork over the $31.50 fee, they’ll have their $10,000 back.): Continue reading Applied Mathematics Letters posts apology for retracting Intelligent Design-friendly paper

No academic matter: Study links retractions to patient harm

Flawed research that leads to retractions is a problem for editors, publishers and the scientific community. But what about patients?

In a recent issue of the Journal of Medical Ethics, R. Grant Steen asks the question — and answers it in the affirmative.

We’ve heard from Steen before; he has written two recent papers on the scope of retractions, finding that the number of retractions seems to be rising faster than the number of publications on the shelves.

This time, Steen takes a crack at ferreting out what he calls “harm by influence,” the admittedly subtle effect that troubled studies have on downstream research. His findings certainly raise concerns. Continue reading No academic matter: Study links retractions to patient harm

Update on Journal of Neuroscience retractions: Authors being investigated. Plus, editor explains why notices say nothing

We have updates on the two mysterious Journal of Neuroscience retractions we reported on yesterday. One is that we have learned that there is a university investigation into the work of one of the teams that retracted one of the studies. More on that in a bit.

Two, the journal’s editor, John Maunsell, responded to our request for comment, and we’re quoting his entire email (with annotation) because we think it raises important issues: Continue reading Update on Journal of Neuroscience retractions: Authors being investigated. Plus, editor explains why notices say nothing

Journal of Neuroscience retracts two, one 13 years old

The June 8 issue of the Journal of Neuroscience includes two retractions:

The notices are completely uninformative. They read: Continue reading Journal of Neuroscience retracts two, one 13 years old

Elsevier apologizes for Applied Mathematics Letters retraction, pays author’s legal fees

Elsevier, the publisher of Applied Mathematics Letters, which retracted a paper questioning the second law of thermodynamics earlier this year, will issue an apology and pay $10,000 in legal fees.

According to John West at the Discovery Institute’s blog, which broke the story: Continue reading Elsevier apologizes for Applied Mathematics Letters retraction, pays author’s legal fees

Three more withdrawals for Naoki Mori, and a hint of the mother of retractions

Lest readers of Retraction Watch had forgotten about Naoki Mori, the cancer researcher who liked his Western blots so much he decided to reuse them — and reuse them some more — he’s back.

The British Journal of Haematology (BJH) has retracted two papers Mori published in that journal, and BMC Microbiology has retracted another, bringing the total of retractions involving his work to at least 19 by our count. [See update at end.]

The BJH issued both retractions online in the end of February, and they’ve since come out in print. Here’s the retraction notice for the first paper, in the BJH (first only because it was published first): Continue reading Three more withdrawals for Naoki Mori, and a hint of the mother of retractions

A third Milena Penkowa paper, in FASEB Journal, now subject to Notice of Concern

As we reported earlier this week, two journals have issued Expressions of Concern about papers by Milena Penkowa, who is under investigation for scientific misconduct and misuse of grants. Now we learn that the FASEB Journal has published a Notice of Concern about a third paper: Continue reading A third Milena Penkowa paper, in FASEB Journal, now subject to Notice of Concern

Another Bulfone-Paus paper under review, this one in Blood

Blood tells Retraction Watch that they are reviewing a 1999 paper co-authored by Silvia Bulfone-Paus, who has already retracted 12 papers in other journals.

The study, “Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15,” has been cited 124 times, according to Thomson Scientific’s Web of Knowledge. Its corresponding author is Tiziana Musso, of the University of Turin.

Joerg Zwirner, over at the Abnormal Science blog, has a three-part series deconstructing what he says are the flaws in the paper. Zwirner points out a number of data duplications. As he notes: Continue reading Another Bulfone-Paus paper under review, this one in Blood

Science asks authors to retract XMRV-chronic fatigue syndrome paper; when they refuse, issue Expression of Concern

It’s Expression of Concern Day here at Retraction Watch. Earlier, we reported on two such notices regarding the complicated case of Milena Penkowa. And now we learn that a 2009 Science paper linking XMRV, or xenotropic murine leukemia-related virus, to chronic fatigue syndrome  (CFS) that has been dogged by questions from the start, is the subject of another Expression of Concern. Such expressions, as we’ve noted, often, but do not always, precede retractions.

The Wall Street Journal reports that Science editor-in-chief Bruce Alberts and executive editor Monica Bradford asked the authors of the paper to retract it last week, after two studies scheduled to published in this week’s Science threw even more doubt onto the findings. But “study co-author Judy A. Mikovits of the Whittemore Peterson Institute for Neuro-Immune Disease said “it is premature to retract our paper,” leading Alberts to issue the Expression of Concern, which begins: Continue reading Science asks authors to retract XMRV-chronic fatigue syndrome paper; when they refuse, issue Expression of Concern